Clinicopathological features and prognostic factors of AIDS-related lymphoma: a retrospective single-center study in China

被引:0
作者
Liang, Ying [1 ]
Chang, Jing [2 ]
Gao, Yuxue [3 ]
Sun, Lin [2 ]
Yue, Zhujun [2 ]
Meng, Lingjia [2 ]
Guo, Caiping [1 ]
Zhang, Yulin [4 ,5 ]
机构
[1] Capital Med Univ, Beijing Youan Hosp, Clin & Res Ctr Infect Dis, Beijing Key Lab HIV AIDS Res, Beijing 100069, Peoples R China
[2] Capital Med Univ, Beijing Youan Hosp, Dept Pathol, Beijing 100069, Peoples R China
[3] Capital Med Univ, Beijing Inst Hepatol, Beijing Youan Hosp, Beijing 100069, Peoples R China
[4] Capital Med Univ, Beijing Youan Hosp, Dept Resp & Crit Care Med, Beijing 100069, Peoples R China
[5] Capital Med Univ, Lab Clin Med, Beijing 100069, Peoples R China
关键词
AIDS; Lymphoma; ARL; NHL; HL; Prognostic; ACTIVE ANTIRETROVIRAL THERAPY; HIV-ASSOCIATED LYMPHOMA; NON-HODGKIN-LYMPHOMA; B-CELL LYMPHOMA; BURKITT-LYMPHOMA; SURVIVAL; RITUXIMAB; INFECTION; EPIDEMIOLOGY; CHEMOTHERAPY;
D O I
10.1007/s00277-025-06424-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AIDS-related lymphoma (ARL) is a leading cause of mortality among people living with HIV (PLWH), characterized by distinct clinicopathological features and a generally poor prognosis. However, comprehensive studies on ARL remain limited. This study aimed to evaluate the clinicopathological characteristics, immune status, and Epstein-Barr virus (EBV)/HIV viral loads in PLWH diagnosed with lymphoma, and to assess their prognostic significance. A retrospective analysis was conducted on 130 ARL cases diagnosed between 2017 and 2024. The cohort included 56 Burkitt lymphoma (BL), 51 diffuse large B-cell lymphoma (DLBCL), 9 Hodgkin lymphoma (HL), 8 plasmablastic lymphoma (PBL), and 6 T/NK cell lymphoma patients. The median age was 39 years, with 94.6% of patients being male. The 2-year overall survival (OS) rate was 50.6%, with HL showing the highest survival rate (85.7%) and BL the lowest (43.8%). Univariate analysis identified several factors significantly associated with poorer OS in non-Hodgkin lymphoma (NHL), including CD4 + T cell count < 200 cells/<mu>L, presence of B symptoms, Eastern Cooperative Oncology Group (ECOG) performance status >= 2, elevated lactate dehydrogenase (LDH), Ann Arbor Stage III/IV disease, > 1 site with extranodal involvement, and bone marrow involvement (all P < 0.05). Multivariate analysis revealed that CD4 + T cell count < 200 cells/mu L (HR: 2.085, P = 0.026) and elevated LDH (HR: 0.378, P = 0.005) were independent prognostic factors. In conclusion, NHL, particularly BL and DLBCL, is the predominant lymphoma subtype among PLWH. Severe immunodeficiency and elevated LDH may serve as effective prognostic factors for predicting OS in patients with AIDS-related NHL.
引用
收藏
页码:3411 / 3422
页数:12
相关论文
共 60 条
[1]   The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms [J].
Alaggio, Rita ;
Amador, Catalina ;
Anagnostopoulos, Ioannis ;
Attygalle, Ayoma D. ;
Araujo, Iguaracyra Barreto de Oliveira ;
Berti, Emilio ;
Bhagat, Govind ;
Borges, Anita Maria ;
Boyer, Daniel ;
Calaminici, Mariarita ;
Chadburn, Amy ;
Chan, John K. C. ;
Cheuk, Wah ;
Chng, Wee-Joo ;
Choi, John K. ;
Chuang, Shih-Sung ;
Coupland, Sarah E. ;
Czader, Magdalena ;
Dave, Sandeep S. ;
de Jong, Daphne ;
Du, Ming-Qing ;
Elenitoba-Johnson, Kojo S. ;
Ferry, Judith ;
Geyer, Julia ;
Gratzinger, Dita ;
Guitart, Joan ;
Gujral, Sumeet ;
Harris, Marian ;
Harrison, Christine J. ;
Hartmann, Sylvia ;
Hochhaus, Andreas ;
Jansen, Patty M. ;
Karube, Kennosuke ;
Kempf, Werner ;
Khoury, Joseph ;
Kimura, Hiroshi ;
Klapper, Wolfram ;
Kovach, Alexandra E. ;
Kumar, Shaji ;
Lazar, Alexander J. ;
Lazzi, Stefano ;
Leoncini, Lorenzo ;
Leung, Nelson ;
Leventaki, Vasiliki ;
Li, Xiao-Qiu ;
Lim, Megan S. ;
Liu, Wei-Ping ;
Louissaint, Abner, Jr. ;
Marcogliese, Andrea ;
Medeiros, L. Jeffrey .
LEUKEMIA, 2022, 36 (07) :1720-1748
[2]   Hodgkin lymphoma: 2025 update on diagnosis, risk-stratification, and management [J].
Ansell, Stephen M. .
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (12) :2367-2378
[3]   Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma [J].
Barta, S. K. ;
Samuel, M. S. ;
Xue, X. ;
Wang, D. ;
Lee, J. Y. ;
Mounier, N. ;
Ribera, J. -M. ;
Spina, M. ;
Tirelli, U. ;
Weiss, R. ;
Galicier, L. ;
Boue, F. ;
Little, R. F. ;
Dunleavy, K. ;
Wilson, W. H. ;
Wyen, C. ;
Remick, S. C. ;
Kaplan, L. D. ;
Ratner, L. ;
Noy, A. ;
Sparano, J. A. .
ANNALS OF ONCOLOGY, 2015, 26 (05) :958-966
[4]   A new prognostic score for AIDS-related lymphomas in the rituximab-era [J].
Barta, Stefan K. ;
Xue, Xiaonan ;
Wang, Dan ;
Lee, Jeannette Y. ;
Kaplan, Lawrence D. ;
Ribera, Josep-Maria ;
Oriol, Albert ;
Spina, Michele ;
Tirelli, Umberto ;
Boue, Francois ;
Wilson, Wyndham H. ;
Wyen, Christoph ;
Dunleavy, Kieron ;
Noy, Ariela ;
Sparano, Joseph A. .
HAEMATOLOGICA, 2014, 99 (11) :1731-1737
[5]   HIV/AIDS Associated Lymphoma: Review [J].
Berhan, Ayenew ;
Bayleyegn, Biruk ;
Getaneh, Zegeye .
BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2022, 12 :31-45
[6]   Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era [J].
Besson, Caroline ;
Lancar, Remi ;
Prevot, Sophie ;
Algarte-Genin, Michele ;
Delobel, Pierre ;
Bonnet, Fabrice ;
Meyohas, Marie-Caroline ;
Partisani, Marialuisa ;
Oberic, Lucie ;
Gabarre, Jean ;
Goujard, Cecile ;
Boue, Francois ;
Coppo, Paul ;
Costello, Regis ;
Hendel-Chavez, Houria ;
Mekerri, Nawel ;
Dos Santos, Gabriella ;
Recher, Christian ;
Delarue, Richard ;
Casasnovas, Rene-Olivier ;
Taoufik, Yassine ;
Mounier, Nicolas ;
Costagliola, Dominique .
AIDS, 2017, 31 (18) :2493-2501
[7]   Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy [J].
Bonnet, F ;
Lewden, C ;
May, T ;
Heripret, L ;
Jougla, E ;
Bevilacqua, S ;
Costagliola, D ;
Salmon, D ;
Chêne, G ;
Morlat, P .
CANCER, 2004, 101 (02) :317-324
[8]   c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma [J].
Bouroumeau, Antonin ;
Bussot, Lucile ;
Bonnefoix, Thierry ;
Fournier, Cyril ;
Chapusot, Caroline ;
Casasnovas, Olivier ;
Martin, Laurent ;
McLeer, Anne ;
Col, Edwige ;
David-Boudet, Laurence ;
Lefebvre, Christine ;
Algrin, Caroline ;
Raskovalova, Tatiana ;
Jacob, Marie-Christine ;
Vettier, Claire ;
Chevalier, Simon ;
Callanan, Mary B. ;
Gressin, Remy ;
Emadali, Anouk ;
Sartelet, Herve .
JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2021, 7 (06) :604-615
[9]   British HIV Association guidelines for HIV-associated malignancies 2014 [J].
Bower, Mark ;
Palfreeman, A. ;
Alfa-Wali, Maryam ;
Bunker, Chris ;
Burns, Fiona ;
Churchill, Duncan ;
Collins, Simon ;
Cwynarski, Kate ;
Edwards, Simon ;
Fields, Paul ;
Fife, Kate ;
Gallop-Evans, Eve ;
Kassam, Shireen ;
Kulasegaram, Ranjababu ;
Lacey, Charles ;
Marcus, Robert ;
Montoto, Sylvia ;
Nelson, Mark ;
Newsom-Davis, Tom ;
Orkin, Chloe ;
Shaw, Kate ;
Tenant-Flowers, Melinda ;
Webb, Andrew ;
Westwell, Sarah ;
Williams, Matt .
HIV MEDICINE, 2014, 15 :1-92
[10]   The Many Facets of CD38 in Lymphoma: From Tumor-Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy [J].
Calabretta, Eleonora ;
Carlo-Stella, Carmelo .
CELLS, 2020, 9 (04)